EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intrathecal baclofen pump for severe hypertonia in a patient with juvenile Huntington’s disease: illustrative case

Graham M Winston, Parsa Nilchian, Jeffrey P Greenfield, Dara Jones

Journal of Neurosurgery: Case Lessons · 02.12.2024 · 8 (23)

DOI: 10.3171/case24512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery: Case Lessons, erschienen am 02.12.2024. Verfasst von Graham M Winston und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurological Surgery, Weill-Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND While the symptoms of Huntington’s disease (HD) typically first appear around the age of 40 years, 5%–10% of patients experience symptoms before the age of 21 years, in which case it is classified as juvenile Huntington’s disease (JHD). JHD poses a unique clinical problem, as affected patients experience rapid deterioration in their quality of life as the motor manifestations of the disease become overwhelming. Medical treatment options for HD are sparse, and the only Food and Drug Administration–approved medication for the treatment of HD is the VMAT-2 inhibitor tetrabenazine. Unfortunately, treatments for JHD are even more limited, as investigational new drugs for HD oftentimes exclude patients with JHD from trials. OBSERVATIONS Here, the authors present the case of a 15-year-old male with severe hypertonia and dystonic events secondary to JHD that was successfully treated with an intrathecal baclofen (ITB) pump. The patient experienced an improvement in hypertonia and a reduction in the frequency of dystonic events after ITB pump implantation, resulting in overall improved patient comfort. LESSONS This case highlights the potential benefits of ITB therapy in managing debilitating hypertonia-type symptoms in patients with JHD. Given the limited treatment options for JHD, this intervention has the potential to profoundly enhance the quality of life for affected individuals. https://thejns.org/doi/10.3171/CASE24512

Schlagwörter

Stichwörter der Autor:innen

intrathecal baclofen pumpjuvenile Huntington’s diseasesevere hypertonia

Autor:innen und Institutionen

  • Departments of Neurological Surgery, Weill-Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York.
  • Physical Medicine and Rehabilitation, Weill-Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Winston, G. M., Nilchian, P., Greenfield, J. P., & Jones, D. (2024). Intrathecal baclofen pump for severe hypertonia in a patient with juvenile Huntington’s disease: illustrative case. Journal of Neurosurgery: Case Lessons, 8(23). https://doi.org/10.3171/case24512

Vancouver

Winston GM, Nilchian P, Greenfield JP, Jones D. Intrathecal baclofen pump for severe hypertonia in a patient with juvenile Huntington’s disease: illustrative case. Journal of Neurosurgery: Case Lessons. 2024;8(23). doi:10.3171/case24512

BibTeX
@article{Winston2024,
  author = {Winston, Graham M and Nilchian, Parsa and Greenfield, Jeffrey P and Jones, Dara},
  title = {Intrathecal baclofen pump for severe hypertonia in a patient with juvenile Huntington’s disease: illustrative case},
  journal = {Journal of Neurosurgery: Case Lessons},
  year = {2024},
  volume = {8},
  number = {23},
  doi = {10.3171/case24512}
}
Kostenlos starten →